DBJ Capital
VC Fund
Otemachi, Japan
DBJ Capital is a VC fund in Otemachi focused on Software and Health Care. DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc. At DBJ Capital, we focus on venture firms which use new technologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks. We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market. DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
- Total investments:
- 168
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries DBJ Capital invests in
Stages DBJ Capital invests in
Countries DBJ Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $2.4M–$17M
- Series B
- $4.6M–$34M
- Venture - Series Unknown
- $887k–$9.5M
Investment Focus
Industry
- Software 16 (10%)
- Health Care 16 (10%)
- Biotechnology 16 (10%)
- Information Technology 13 (8%)
- Medical 12 (7%)
Stage
- Series A 41 (24%)
- Venture - Series Unknown 33 (20%)
- Series B 27 (16%)
- Seed 20 (12%)
- Funding Round 13 (8%)
Country
- Japan 119 (71%)
- United States 2 (1%)
- Australia 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Akama Sho
Senior Investment Manager
|
Senior Investment Manager | Total investments: 1 | Find email | |
|
Daiki Ito
Investment Manager
|
Investment Manager | Total investments: 1 | Find email | |
Haruhiko Uchiyama
President and CEO
|
President and CEO | Total investments: 1 | Find email | |
|
Hisashi Mitsuguchi
Auditor
|
Auditor | Total investments: 1 | Find email | |
|
Shingo Isobe
Senior Investment Manager
|
Senior Investment Manager | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MOT manages and supports the business activities of writers, particularly manga artists, while also operating “Kakikomi,” an online manga school that provides aspiring artists with education, guidance, and practical training to develop their creative skills. | Seed / Oct 02, 2026 | ||
| Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology. | $3.3M / Series F / Oct 01, 2026 | ||
| Facilo is a real estate communication provider that uses cloud computing to enhance sales and ease transactions of real estate brokerage. | $25M / Series B / Sep 17, 2026 | ||
| Power Laser is a startup company that offers a range of power laser technologies and applications. The company develops high-power laser systems, related components, and software for advanced industrial and scientific applications. Its mission, “Power lasers open the future,” reflects its focus on next-generation photonics and precision laserinnovation for manufacturing and research sectors. | $7.5M / Series A / Sep 02, 2026 | ||
| Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors. | $105.3M / Series D / Aug 24, 2026 | ||
| Creatura assists companies in reducing greenhouse gas emissions by generating and distributing carbon credits and promoting the adoption of renewable energy sources. | $6.3M / Series B / Aug 07, 2026 | ||
| Arrowsmith is committed to unlocking the full potential of bacteriophages to revolutionize the treatment of bacterial infectious diseases. Through transformative science, Arrowsmith strive to create a world free from the pain and fear caused by antimicrobial resistance. | $6.5M / Series A / Jun 22, 2026 | ||
| Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic. | $442.5M / May 28, 2026 | ||
| Shonai is a real estate company that focuses on the development of residential and commercial properties. | $1.3M / Venture - Series Unknown / Apr 30, 2026 | ||
| Oceanic Constellations empowers ocean visualization with a network of autonomous surface drones and advanced marine monitoring technology. | $13.1M / Series B / Feb 12, 2026 | ||
| See all 168 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does DBJ Capital invest in?
DBJ Capital invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Venture - Series Unknown stage. Most of the 168 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does DBJ Capital invest in?
DBJ Capital typically joins rounds of $2.4M–$17M at Series A, $4.6M–$34M at Series B and $887k–$9.5M at Venture - Series Unknown. These are whole funding-round sizes, not DBJ Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds DBJ Capital took part in.
How do I contact DBJ Capital?
Public channels for DBJ Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at DBJ Capital?
The team at DBJ Capital includes Akama Sho (Senior Investment Manager), Daiki Ito (Investment Manager) and Haruhiko Uchiyama (President and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
